Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
-
Multicenter Study
An Open-Label, Multicenter, Evaluator-Blinded Study to Assess the Efficacy and Safety of a New Hyaluronic Acid-Based Gel Product for Lip Enhancement.
A stabilized hyaluronic acid (HA)-based lidocaine-containing gel of nonanimal origin has been developed for lip enhancement. ⋯ Lip enhancement with this HA-based gel generated high subject satisfaction and natural-looking lips. The effect lasted for up to 9 months according to the GAIS ratings by subjects and independent evaluators. The product was well tolerated; most AEs were mild-to-moderate local injection site reactions.
-
Randomized Controlled Trial Multicenter Study
Duration of effect by injection volume and facial subregion for a volumizing hyaluronic acid filler in treating midface volume deficit.
Juvéderm Voluma XC (VYC-20L) is approved in the United States for correction of age-related volume loss in the midface region in adults. ⋯ VYC-20L is effective at restoring midface volume, with high subject satisfaction and an acceptable safety profile.
-
Letter Multicenter Study
Dermatological surgery—time for single-use instruments?
-
A third-generation microwave-based device has been developed to treat axillary hyperhidrosis by selectively heating the interface between the skin and underlying fat where the sweat glands reside. ⋯ The device tested provided efficacious and durable treatment for axillary hyperhidrosis.
-
Randomized Controlled Trial Multicenter Study Comparative Study
Comparison of injection comfort of a new category of cohesive hyaluronic acid filler with preincorporated lidocaine and a hyaluronic acid filler alone.
A smooth, cohesive, 24-mg/mL hyaluronic acid (HA) gel with uniform consistency, even flow characteristics, and extended duration was designed for injection into the mid to deep dermis. ⋯ The smooth, cohesive HA gel with preincorporated lidocaine increased subject comfort during treatment and improved the injection experience.